Biological and clinical data show that Syncytin is expressed by other breast carcinoma cell lines, like MCF7 and MDA-MB-231, and by approximately one third of 165 human ductal lymphnodes-negative breast cancers, and that in these tumors its expression is associated to a favourable clinical course of the disease [28, 29]. Here, ERVW-1 is linked to breast carcinoma.